Famciclovir Suspension

Famciclovir functions as a high-affinity prodrug that is rapidly converted to its active metabolite, penciclovir, to selectively inhibit viral DNA polymerase and halt the replication of herpes simplex and varicella-zoster viruses. The suspension’s precisely engineered excipient profile works in synergy with the active moiety to ensure optimal stability and uniform drug distribution, facilitating consistent bioavailability and reliable therapeutic performance. This liquid delivery format provides essential clinical versatility through customizable weight-based dosing and improved ease of administration, effectively addressing the needs of pediatric or geriatric populations who may struggle with traditional solid oral dosage forms.